Literature DB >> 7514060

Anatomy of the action potential in the heart.

H T Shih1.   

Abstract

The surface electrocardiogram can be simply described as the P, QRS, and T (and U) waves, together with PR and ST segments. However, it is actually the summation of the action potential from the sinoatrial node, the atria, the atrioventricular node, the His-Purkinje system, and the ventricles. Although the action potential can be divided grossly into 5 phases, its characteristics vary in different cardiac tissue. This is because the action potential is the end-result of multiple ion channels, pumps, and exchangers opening and closing in concert, and the properties and distribution of these components can be different from one tissue to another. The ion channels can be activated by changes in the membrane voltage and specific ligands, and can be modulated by factors such as neurotransmitters (e.g., through the G-protein system), the G-proteins directly, or other ions. Only in the last 10 years have investigators been able to use molecular biology techniques to peek into the primary structure of ion channels and to develop more workable models of the channel functions. The primary structure and the putative secondary structure of the ion channels show resemblance among the groups, suggesting that, except for IsK, the development of ion channels started with IK1 and IK(ACh), followed by Ito and IK, and then by INa and ICa. However, limitations still exist in our knowledge of the ion channels and hence of the action potential. This is demonstrated by the lack of effective pharmacologic treatment of cardiac arrhythmias to this date. It is to be hoped that advances in cell electrophysiology, genetic engineering, and molecular imaging techniques will soon end the dark days of antiarrhythmic therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514060      PMCID: PMC325129     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  6 in total

1.  Simplified gene nomenclature.

Authors:  K G Chandy
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Primary structure and functional expression of a mouse inward rectifier potassium channel.

Authors:  Y Kubo; T J Baldwin; Y N Jan; L Y Jan
Journal:  Nature       Date:  1993-03-11       Impact factor: 49.962

Review 3.  Cardiac ion channels.

Authors:  A M Katz
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

4.  Cloning of a membrane protein that induces a slow voltage-gated potassium current.

Authors:  T Takumi; H Ohkubo; S Nakanishi
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

5.  Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel.

Authors:  Y Kubo; E Reuveny; P A Slesinger; Y N Jan; L Y Jan
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

6.  Alternative splicing of CFTR Cl- channels in heart.

Authors:  B Horowitz; S S Tsung; P Hart; P C Levesque; J R Hume
Journal:  Am J Physiol       Date:  1993-06
  6 in total
  13 in total

1.  Hydrogen Sulfide Targets the Cys320/Cys529 Motif in Kv4.2 to Inhibit the Ito Potassium Channels in Cardiomyocytes and Regularizes Fatal Arrhythmia in Myocardial Infarction.

Authors:  Shan-Feng Ma; Yan Luo; Ying-Jiong Ding; Ying Chen; Shi-Xin Pu; Hang-Jing Wu; Zhong-Feng Wang; Bei-Bei Tao; Wen-Wei Wang; Yi-Chun Zhu
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

2.  A characterization of the electrophysiological properties of the cardiomyocytes from ventricle, atrium and sinus venosus of the snake heart.

Authors:  Denis V Abramochkin; Vladimir Matchkov; Tobias Wang
Journal:  J Comp Physiol B       Date:  2019-12-18       Impact factor: 2.200

3.  High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging.

Authors:  Neil J Daily; Zhong-Wei Du; Tetsuro Wakatsuki
Journal:  Assay Drug Dev Technol       Date:  2017-05-19       Impact factor: 1.738

Review 4.  Mitochondrial Ca2+, redox environment and ROS emission in heart failure: Two sides of the same coin?

Authors:  Sonia Cortassa; Magdalena Juhaszova; Miguel A Aon; Dmitry B Zorov; Steven J Sollott
Journal:  J Mol Cell Cardiol       Date:  2020-12-07       Impact factor: 5.000

5.  Prediction of Cardiac Mechanical Performance From Electrical Features During Ventricular Tachyarrhythmia Simulation Using Machine Learning Algorithms.

Authors:  Da Un Jeong; Ki Moo Lim
Journal:  Front Physiol       Date:  2020-11-24       Impact factor: 4.566

Review 6.  Mechanisms underlying electro-mechanical dysfunction in the Zucker diabetic fatty rat heart: a model of obesity and type 2 diabetes.

Authors:  Ahmed Sultan; Jaipaul Singh; Frank Christopher Howarth
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

7.  Intracellular Ca2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells.

Authors:  Philipp Sasse; Jianbao Zhang; Lars Cleemann; Martin Morad; Juergen Hescheler; Bernd K Fleischmann
Journal:  J Gen Physiol       Date:  2007-08       Impact factor: 4.086

8.  Characterisation of connexin expression and electrophysiological properties in stable clones of the HL-1 myocyte cell line.

Authors:  Priyanthi Dias; Thomas Desplantez; Majd A El-Harasis; Rasheda A Chowdhury; Nina D Ullrich; Alberto Cabestrero de Diego; Nicholas S Peters; Nicholas J Severs; Kenneth T MacLeod; Emmanuel Dupont
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  The effect of myocardial action potential duration on cardiac pumping efficacy: a computational study.

Authors:  Da Un Jeong; Ki Moo Lim
Journal:  Biomed Eng Online       Date:  2018-06-15       Impact factor: 2.819

Review 10.  iPSC-Cardiomyocyte Models of Brugada Syndrome-Achievements, Challenges and Future Perspectives.

Authors:  Aleksandra Nijak; Johan Saenen; Alain J Labro; Dorien Schepers; Bart L Loeys; Maaike Alaerts
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.